We are live on ! Find out more
EVH icon

Evolent Health
EVH

131 hedge funds and large institutions have $921M invested in Evolent Health in 2017 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more call options, than puts

Call options by funds: $5.97M | Put options by funds: $1.3M

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

111% more capital invested

Capital invested by funds: $435M → $921M (+$485M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

63% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 30

22.89% more ownership

Funds ownership: 55.96% → 78.85% (+23%)

11% more funds holding

Funds holding: 118 → 131 (+13)

Holders
131
Holders Change
+13
Holders Change %
+11.02%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
36
Increased
49
Reduced
30
Closed
17
Calls
$5.97M
Puts
$1.3M
Net Calls
+$4.68M
Net Calls Change
+$2.88M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$53.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$43.9M
3
Invesco
Invesco
Georgia
+$40.7M
4
PA
Perceptive Advisors
New York
+$21.8M
5
Millennium Management
Millennium Management
New York
+$21.2M

Top Sellers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
-$34.1M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$9.85M
3
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$7.4M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$5.93M
5
PC
Pier Capital
Connecticut
-$4.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
126
UBS Group
Switzerland
$9K -$72.3K -3,766 -90%
Creative Planning
127
Creative Planning
Kansas
$9K – – –
AG
128
Advisor Group
Arizona
$4K -$1.92K -100 -33%
SIAP
129
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$4K – – –
SF
130
Synovus Financial
Georgia
$3K +$2.88K +150 New
QI
131
QS Investors
New York
$1K +$537 +28 +127%
TWA
132
TCI Wealth Advisors
Arizona
$1K +$614 +32 New
Loomis, Sayles & Company
133
Loomis, Sayles & Company
Massachusetts
– -$5.93M -400,607 Closed
PC
134
Pier Capital
Connecticut
– -$4.64M -313,669 Closed
NIP
135
Nicholas Investment Partners
California
– -$1.94M -131,169 Closed
HCM
136
Highbridge Capital Management
New York
– -$1.39M -93,925 Closed
LOAMU
137
Lombard Odier Asset Management (USA)
New York
– -$1.18M -80,000 Closed
Two Sigma Advisers
138
Two Sigma Advisers
New York
– -$901K -60,900 Closed
Squarepoint
139
Squarepoint
New York
– -$490K -33,087 Closed
D.E. Shaw & Co
140
D.E. Shaw & Co
New York
– -$485K -32,744 Closed
TI
141
Trexquant Investment
Connecticut
– -$350K -23,661 Closed
DTL
142
Dynamic Technology Lab
Singapore
– -$332K -22,416 Closed
Verition Fund Management
143
Verition Fund Management
Connecticut
– -$295K -19,950 Closed
Prudential Financial
144
Prudential Financial
New Jersey
– -$245K -16,570 Closed
BCM
145
Bayesian Capital Management
New York
– -$234K -15,821 Closed
LCM
146
Landscape Capital Management
New Jersey
– -$160K -10,833 Closed
TMC
147
Trellus Management Company
Florida
– -$148K -10,000 Closed
Group One Trading
148
Group One Trading
Illinois
– -$6.83K -356 Closed
CPIG
149
Chicago Partners Investment Group
Illinois
– -$4K -300 Closed
2 3 4 5
6

EVH Hedge Fund Activity: Q1 2017 in Review

131 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2017, worth a combined $921M — up 111% from $435M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new EVH positions and 17 closed out — a net gain of 19 holders — while 49 added to existing stakes and 30 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $53.6M. The largest seller was Granahan Investment Management, cutting an estimated $34.1M.

  • 131 institutional investors held Evolent Health (EVH) as of Q1 2017, up from 118 in Q4 2016.
  • Funds reported $921M of Evolent Health stock for Q1 2017, up 111% quarter-over-quarter.
  • 36 funds opened new Evolent Health positions in Q1 2017 and 17 closed out, a net change of +19 holders.
  • The largest Evolent Health buyer in Q1 2017 was JP Morgan Chase, an estimated $53.6M added.
  • The largest Evolent Health seller in Q1 2017 was Granahan Investment Management, an estimated $34.1M sold.

Based on aggregated 13F filings for Q1 2017.